is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2), the virus that causes coronavirus disease 2019 (COVID‑19).
Pfizer Inc. and BioNTech SE announced today a new vaccine supply agreement with the U.S. government, according to which the U.S. government will receive...
Sanofi and GSK today announce positive data from their vaccine trial which evaluated an adjuvanted bivalent D614 and Beta vaccine candidate. Sanofi-GSK’s vaccine is...
U.S. biotech firm Moderna will build a new research and manufacturing centre in Britain to develop vaccines against new COVID-19 variants, other respiratory illnesses...
Moderna stock and Novavax stock suffered contrasting fortunes in premarket trading on Wednesday after positive updates for both companies regarding their COVID-19 vaccines.
Moderna stock...